Predictive Technology Group, Inc. (PRED)
EXPM Summary
PRED Chart
Predictive Technology Group, Inc. (PRED) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Predictive Technology Group, Inc. ever had a stock split?
Predictive Technology Group, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Bradley C. Robinson CEO | EXPM Exchange | US74039H1023 ISIN |
| US Country | 62 Employees | - Last Dividend | 29 Jul 2010 Last Split | - IPO Date |
Overview
Predictive Technology Group, Inc., operates through its subsidiaries, focusing on the development and commercialization of advanced molecular diagnostic, therapeutic solutions, and human cellular and tissue-based products (HCT/Ps). It functions across two primary segments: Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company has its foundation in novel genetic testing services and regenerative medicine applications, providing innovative solutions for infertility and aiding in the selection of cancer patients for treatment through a collaboration agreement with Atrin Pharmaceuticals LLC. Changing its name from Global Enterprises Group, Inc. in July 2015, Predictive Technology Group, Inc. was established in 2005 and has its headquarters in Salt Lake City, Utah. Notably, on November 9, 2023, the company filed for Chapter 11 bankruptcy, which was later converted to Chapter 7 on January 12, 2024, marking a significant transition in its operational status.
Products and Services
- FertilityDX: This genetic testing service is designed for couples experiencing infertility, offering them insights and guidance on their journey towards conception.
- ARTguide: Tailored for women dealing with infertility related to endometriosis and other genetic conditions, ARTguide is a genetic test that aims to facilitate a better understanding and management of their condition.
- Regenerative Medicine Products:
- AmnioCyte: A product designed for use in regenerative medicine applications, offering prospects for tissue regeneration and healing.
- AmnioCyte Plus: An advanced version of AmnioCyte, providing enhanced regenerative capabilities.
- PolyCyte: Another regenerative medicine product, PolyCyte is formulated to support tissue repair and regeneration.
- CoreCyte: Focused on core cellular therapies, CoreCyte is used in various regenerative medicine applications to foster healing and recovery.
Contact Information
